Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Themes | Quick Take |
|---|---|---|---|---|---|---|---|
Buyside Digest is not affiliated with, and does not endorse, Long Cast Advisers. This analysis is provided for institutional research purposes only and is not investment advice.
"Small-cap specialist delivered flat Q1 returns but maintains 13% CAGR since 2015 through concentrated positions in exceptional management teams. Key holdings MTRX, PDEX, and MAMA offer compelling value with strong operational improvements."
Long Cast Advisers delivered flat returns in 1Q26, matching small-cap benchmarks despite geopolitical turmoil from Iran war, inflation, and AI market dynamics. Since inception in 2015, the fund has generated 270% cumulative returns (13% CAGR) through concentrated investing in small and micro-cap companies. The strategy focuses on exceptional management teams, taking 5-15 positions targeting five-year doubles. Key holdings include MTRX, which reported its first profitable quarter with attractive 7x EV/EBITDA valuation; PDEX, positioned to benefit from Zimmer Biomet's medical device commercialization; and MAMA, which has grown book value dramatically under new leadership. The manager views AI as a useful tool rather than an existential threat, believing companies that adapt will thrive. Portfolio changes included adding to NRC and CCRN while exiting RELL and ENVX. With CCRN's acquisition closing, the fund currently holds excess cash for future deployment.
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Market Conviction
The manager holds an extremely concentrated portfolio, with the top five positions accounting for 62% of assets. The writing displays high conviction in named long positions (like MAMA, PDEX, MTRX), supported by granular analysis and management diligence.
Growth Outlook
The manager remains neutral on broad market directions, focusing instead on individual small-cap execution. While noting macro and geopolitical turmoil, they do not make sweeping directional market forecasts.
Risk Appetite
The fund's highly concentrated posture and focus on micro-cap and small-cap 'five-year doubles' reflect a high risk appetite, although they currently hold some excess cash which slightly tempers the score.
Capital Deployment
The manager raised capital by exiting several positions (including RELL and the acquired CCRN), resulting in excess cash and a slightly net neutral to defensive deployment posture.
Forward Guidance
The manager expresses a balanced deployment posture, noting that they currently hold excess cash from exits and acquisitions and are waiting for appropriate entry points.
Language Signal
Constructive and highly optimistic language is used when detailing top holdings like MAMA, PDEX, and MTRX, offset by realistic appraisals of exited positions.
Perceived Risk
The manager identifies specific external risks including inflation, geopolitical conflicts, and market overreactions/herding around AI expectations, presenting a cautious view of the macro environment.
Opportunity Density
The manager identifies specific, highly attractive opportunities in select small-caps but is exercising patience and currently holds cash rather than seeing a broad abundance of cheap ideas.
Time Horizon
The fund's stated philosophy is patient, long-term investing with an explicit target of five-year doubles, reflecting a multi-year investment horizon.
